UNSPSC 85725131: Revision of autologous tissue substitute in lumbosacral disc, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in lumbosacral disc, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SW437Z

UNSPSC 85725131 Revision of autologous tissue substitute in lumbosacral disc, percutaneous approach is a Commodity code that shows no relevant recent activity in state and local procurement. The six most recently posted opportunities under this code span independent medical evaluations for public safety pension disability determinations, surgical benefit carve-out programs for municipal employees, occupational medical surveillance for state ferry workers, emergency and specialty medical services for youth in detention, pharmacy benefit management, and temporary health professional staffing—none of which involve autologous tissue substitutes, lumbosacral disc revision procedures, or percutaneous spinal intervention. The code's nominal scope describes a surgical implant or regenerative medicine procedure, whereas the tagged opportunities reflect administrative health services, benefits program management, and staffing placement. The mismatch suggests either systematic miscoding in the state and local procurement system or that this code has not drawn relevant solicitation activity in recent months.

State and local buyers posting under this code include city retirement offices (City of Phoenix), municipal human resources departments (City of Long Beach), state transportation agencies (Washington State Department of Transportation), county probation departments (Harris County Juvenile Probation Department), county commissioners (Collier County, Santa Clara County), and regional health systems (County of Santa Clara Health System). Geographic distribution spans Arizona, California, Florida, and Washington, with no dominant jurisdiction. Without opportunities aligned to the code's actual commodity scope, the code presents limited procurement intelligence for vendors offering spinal implants, biologics, or orthopedic surgical products.